Global Cap.Mkt. (530263)
Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹0.85 |
| Market Cap | ₹35.33 Cr |
| P/E Ratio | 17.4 |
| ROCE | -1.77% |
| ROE | 2.53% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹0.44 — ₹0.85 |
| Sector | Finance |
| Book Value | ₹1.18 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
This is a classic Graham-style cigar butt. At ₹0.85 against book value of ₹1.18, I can buy a rupee of net assets for 72 paise. But value investing doesn't end at the balance sheet; I must ask what those assets can earn. The answer is discouraging: ROE is only 2.53%, and ROCE is negative at -1.77%. This NBFC is earning far below any reasonable cost of capital, and the latest quarter shows sales of just ₹1 crore with net profit of essentially nil. Reported sales and profit growth are both 0.00%, so there is no growth engine. The P/E of 17.4 looks rich for a stagnant business, and the PEG of 0.16 contradicts the zero actual profit growth, so I ignore it completely. With no dividend, a minority investor gets no current return and must depend on book value protection or a future turnaround. The F-Score of 6/9 is mildly reassuring and suggests no severe financial distress, but for an NBFC, missing debt/equity and promoter holding data is a red flag. This is not a high-quality compounder; it is a possible asset play, trading at a discount to stated book. However, a discount is only meaningful if asset quality holds and management can redeploy capital better. I would demand much more evidence before putting money here.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer